Hero background pattern

Developing the right pricing strategy for your product

We use a variety of pricing techniques and approaches to recommend the optimum value-based pricing for your product.

How can we support you:
Payer Insights
Pricing Strategy
BD Commercial Assessments
Tactical Pricing

We can help you

  • Obtain payer and stakeholder insights into the perceived value of your product
  • Identify the optimal price for your product
  • Determine the global pricing strategy
  • Understand payer evidence requirements to support your value-based pricing and reimbursement strategy
  • Conduct commercial assessments for business development assets
  • Implement pricing tactics to optimize post-launch pricing at a list and net price level
Get in touch

Discover the latest insights

Italy Icon
AIFA regulatory overhaul marks milestone in Pharma
AIFA’s restructuring in Italy aims to streamline drug approval, replacing committees and introducing…
Read more
What are the 5 Pricing & Market Access trends…
Our experts provide an overview of the five key trends that could shape the pricing and market acces…
Read more
Reflecting on the Pricing & Market Access tre…
Back in January this year, we summarised the key trends our market access experts believed would dom…
Read more
ISPOR Europe 2023
We’re thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We’ll…
Read more
World Orphan Drug Congress Europe 2023 REPORT
We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
NICE’s Proportionate Approach to Technology …
Webinar: Our experts discuss NICE’s proportionate approach to technology appraisals and the implicat…
Read more
ISPOR Europe 2023: Can Just Three PICOs be Feasibl…
This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment…
Read more
ISPOR Europe 2023: How Aware Are Biotech and Pharm…
Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in…
Read more
pharmaceutical law
Germany’s Health Ministry Shifts Focus to Di…
Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de…
Read more
New Additions to HTA International Collaboration
In a ground breaking move, the international collaboration among six prominent health technology ass…
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.